Iqvia Holdings Inc. (IQV)

Sector: Industrials
Industry: Services-Commercial Physical & Biological Research
Country: United States
Exchange: NYSE
Market cap: $41.29B
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Latest financial period: September 30, 2026
Filed with the SEC: October 27, 2026
Estimated earnings date: Not available
Profit #786 of 1422 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROIC | 9.3% | 9.3% | 9.6% | 9.6% |
Growth #931 of 1422 companies
Payout #468 of 1422 companies
Safety #536 of 1422 companies
Price #728 of 1422 companies